Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.590
-0.070 (-2.63%)
At close: Aug 24, 2026, 4:00 PM EDT
2.623
+0.033 (1.25%)
After-hours: Aug 24, 2026, 7:30 PM EDT
Nkarta Market Cap
Nkarta has a market cap or net worth of $185.51 million as of August 24, 2026. Its market cap has increased by 10.21% in one year.
Market Cap
185.51M
Enterprise Value
76.28M
1-Year Change
10.21%
Ranking
Category
Stock Price
$2.59
ChartMarket Cap Chart
Since July 10, 2020, Nkarta's market cap has decreased from $1.46B to $185.51M, a decrease of -87.33%. That is a compound annual growth rate of -28.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 185.51M | 41.17% |
| Dec 31, 2025 | 131.40M | -25.22% |
| Dec 31, 2024 | 175.72M | -45.75% |
| Dec 29, 2023 | 323.88M | 10.77% |
| Dec 30, 2022 | 292.39M | -42.19% |
| Dec 31, 2021 | 505.77M | -74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Satellos Bioscience | 208.17M |
| Corbus Pharmaceuticals Holdings | 200.76M |
| Oramed Pharmaceuticals | 200.08M |
| NervGen Pharma | 199.99M |
| Korro Bio | 194.08M |
| Protalix BioTherapeutics | 191.76M |
| Armata Pharmaceuticals | 189.63M |
| Codexis | 182.87M |